Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023

Contributed by: GlobeNewswire

Tags

HBV

More Like This

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer

Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025

bit.bio's cell therapy pipeline November 2023 (Graphic: Business Wire)

bit.bio Unveils Cell Therapy Pipeline, Including Lead Candidate for Acute Liver Failure, and Significantly Expands Scientific Advisory Board with Global Experts in Cell Therapy

Novotech, a global (CRO) and scientific advisory company, is featured in The Next Frontier, a global branded series presented by BIO and produced by BBC StoryWorks Commercial Productions.

Novotech Showcased in Global Biotech Series for Innovation in Hepatitis B Research

ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting

Novotech Releases Comprehensive Report on Oncolytic Virus Therapy

Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges

Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis